Quantum Pharma PLC (LSE:QP.) - Share price - Overview

Stock Report

Quantum Pharma PLC QP.

Last Price
GBX40.75

Day Change
0.00|0.00%

As of 21/04/2017
09:50:51 BST | GBX
Minimum 15 Minutes Delay.

Last Close40.75p
Day Range40.13 - 40.95
Mkt Cap68.92Mil
52-Wk Range32.75 - 91.70
Yield %1.84
ISINGB00BRTL8Q42
Volume6,300
P/E7.46
P/S0.73
P/CF7.30

Share Price

Total Returns -

 Chg (%)  
More ...
Quantum Pharma PLC- 
 
Financials
201420152016
More ...
Income Statement
Turnover53.4961.7269.99
Operating Profit2.286.676.96
Net Profit-1.910.725.60
Reported EPS-1.300.564.30
Balance Sheet
Current Assets17.9221.3322.84
Non Current Assets57.3061.2184.50
Total Assets75.2282.54107.35
Current Liabilities31.6916.3928.18
Total Liabilities79.1031.8251.84
Total Equity-3.8850.7255.51
Cash Flow
Operating Cash Flow4.592.927.61
Net Change in Cash-1.311.59-1.63
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20176.934.48-18.049.10-0.50--
20188.003.70-17.3211.00-0.64--
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
11/11/2016PurchaseMr. Ian Johnson34.0058,82420,000.00
11/11/2016PurchaseDr. John Brown34.0073,52925,000.00
11/11/2016PurchaseChris Rigg34.00147,05950,000.00

Company Profile

Quantum Pharma PLC is engaged in the manufacture, procurement and supply to UK pharmacy chains, wholesalers and hospitals of Specials and Special Obtains. Specials are medicines which are not licensed for general manufacture.

Sector

Drug Manufacturers - Specialty & Generic

Market Position

1012 of 1850 Companies

Index

FTSE AIM All Share

Outlook

(01/02/2017) "...unaudited group adjusted EBITDA for the year ended 31 January 2017 is expected to be in line with market expectations"

Next Event 03/05/2017

Next prelim announcement
Ratios
CompSecMkt
More ...
PER (E)11.0013.7915.90
Div Yld (E)0.003.894.29
PEG (E)-0.640.320.96
ROCE99.99179.2018.09
Op Mrgn12.13-7.80-0.74
EPS Grwth-17.3272.1428.10
Dividends
PreviousLatest
More ...
Record Date30/10/1521/10/16
Ex-Div29/10/1520/10/16
Paid20/11/1507/11/16
Amnt0.501.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Ian Johnson
Chief Executive OfficerChris Rigg
Chief Financial OfficerGed Murray
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.